home / stock / telo:cc / telo:cc quote
Last: | $0.38 |
---|---|
Change Percent: | -2.56% |
Open: | $0.39 |
Close: | $0.38 |
High: | $0.39 |
Low: | $0.38 |
Volume: | 60,272 |
Last Trade Date Time: | 05/06/2022 04:56:36 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.38 | $0.39 | $0.38 | $0.39 | $0.38 | 60,272 | 05-06-2022 |
$0.39 | $0.4 | $0.39 | $0.4 | $0.39 | 40,602 | 05-05-2022 |
$0.4 | $0.41 | $0.4 | $0.42 | $0.35 | 82,731 | 05-04-2022 |
$0.41 | $0.44 | $0.41 | $0.44 | $0.41 | 9,503 | 05-03-2022 |
$0.42 | $0.47 | $0.42 | $0.47 | $0.42 | 18,851 | 05-02-2022 |
$0.47 | $0.5 | $0.47 | $0.51 | $0.47 | 18,686 | 04-29-2022 |
$0.51 | $0.51 | $0.51 | $0.51 | $0.51 | 2,001 | 04-28-2022 |
$0.46 | $0.47 | $0.46 | $0.47 | $0.46 | 21,700 | 04-27-2022 |
$0.51 | $0.51 | $0.51 | $0.52 | $0.48 | 14,211 | 04-26-2022 |
$0.48 | $0.48 | $0.48 | $0.48 | $0.46 | 50,077 | 04-25-2022 |
$0.49 | $0.46 | $0.49 | $0.49 | $0.46 | 29,000 | 04-22-2022 |
$0.5 | $0.53 | $0.5 | $0.53 | $0.47 | 347,550 | 04-21-2022 |
$0.5 | $0.52 | $0.5 | $0.52 | $0.5 | 70,429 | 04-20-2022 |
$0.51 | $0.51 | $0.51 | $0.53 | $0.51 | 43,000 | 04-19-2022 |
$0.51 | $0.51 | $0.51 | $0.51 | $0.51 | 7,600 | 04-18-2022 |
$0.51 | $0.52 | $0.51 | $0.52 | $0.51 | 53,025 | 04-15-2022 |
$0.51 | $0.52 | $0.51 | $0.52 | $0.51 | 53,025 | 04-14-2022 |
$0.51 | $0.53 | $0.51 | $0.53 | $0.51 | 20,755 | 04-13-2022 |
$0.52 | $0.53 | $0.52 | $0.53 | $0.51 | 37,430 | 04-12-2022 |
$0.54 | $0.51 | $0.54 | $0.55 | $0.5 | 353,524 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Telo Genomics Corp. Company Name:
TELO:CC Stock Symbol:
TSXVC Market:
Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...
Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation and implementation of its machine learning and Artificial Intelligence (AI) modules, u...
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), ( the "Company" or "Telo"), a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications in oncology, is thrilled t...